Navigation Links
Thomson Reuters Survey Finds Cancer Patients Forgoing Treatment Because of Cost
Date:10/13/2008

25 Percent of Late-Stage Patients Earning Under $40,000 Annually Say They

Have Chosen Not to Undergo Recommended Care

ANN ARBOR, Mich., Oct. 13 /PRNewswire/ -- The Healthcare business of Thomson Reuters today announced the publication of a new research report which analyzes the impact of cost on the cancer treatment decisions of individuals.

Entitled "The Cost of Cancer," the report aggregates survey responses from 1,767 adults currently being treated for cancer. It finds a clear link between patients' annual income and their decisions to curb cancer treatments due to cost -- even among patients with late-stage cancers.

The report notes that among the 569 survey respondents with late-stage cancer, 12.3 percent said they have passed up recommended treatment because it was too expensive. This figure varies dramatically by patient income level. Twenty-five percent of late-stage cancer patients who earn less than $40,000 a year said they have chosen not to undergo a recommended treatment due to cost -- compared with 11.2 percent of those earning between $40,000 and $80,000 per year and 4.8 percent of those earning more than $80,000 annually.

Similarly, 65 percent of all respondents with late-stage cancer said the out-of-pocket cost of treating their cancer has caused them distress. Among all cancer patients earning under $40,000 per year, that number jumps to 77 percent.

"The physical and emotional burden of illness is not the only challenge cancer patients face," said Bill Marder, PhD, senior vice president and general manager for the Healthcare business of Thomson Reuters. "Many also struggle to cope with medical costs. This survey shows that the cost of cancer treatment is affecting patients' ability to get the care they need."

Data for the report were aggregated using the Thomson Reuters NexProfiler(TM) Treatment Option Tool to identify and survey patients who are actively being treated for breast cance
'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. The Scientific Business of Thomson Reuters Predicts Nobel Laureates
2. Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters
3. The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008
4. Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey
5. Kansas Health Policy Authority Awards Thomson Reuters Contract for Health Care Data Integration and Analysis Initiative
6. Thomson Reuters Publishes CMR Internationals 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online
7. Thomson Reuters Introduces a New Solution to Boost Competitive Advantage in Chinas Generics and API Market
8. CMS Selects Thomson Reuters to Help Detect Medicaid Fraud in Eight States
9. Thomson Reuters Adds Routes of Synthesis Data to Its Newport Horizon Premium and Newport Vision Premium Solutions
10. The Scientific Business of Thomson Reuters Publishes Pharma Matters - a Series of Reviews Covering Various Aspects of the Pharmaceutical Pipeline
11. Thomson Reuters Honors Temple University Health System for Initiative That Cut Costs $64 Million and Grew Clinical Service Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Wine World Accessories, a renowned online store ... attractive 25% discount on Franmara Dynamo Electric Wine ... purchase this electric corkscrew opener for $44.95 via Wine ... online store ensures delivery of their items within 1-2 ... , A spokesperson from the online store elaborates the ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Medical device company, ... for its much anticipated mobility aid with its namesake, the ... a hands-free crutch alternative that injured individuals can ... ankle, for example, can remain active and walk during a ... using its reservation system to ensure those who need the ...
(Date:5/18/2013)... 2013 Three new locations will be ... wellness centers and one therapeutic dispensary. Patient Appreciation Fair ... weekend of May 25th – May 27th, particularly honoring ... All events will take place from 11:00 ... Elements Therapeutic Dispensary , 10580 S. State Route 69, ...
(Date:5/17/2013)... inflict lasting damage to brain regions associated with fear ... stress disorder, or PTSD, have shown that these brain ... such as recalling a traumatic event or reacting to ... NYU School of Medicine have explored for the first ... with PTSD in the absence of external triggers. ...
Breaking Medicine News(10 mins):Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2
... of Facial Plastic Surgery, an innovative technique in African American rhinoplasty ... ... New York, NY (PRWEB) July 18, 2008 -- In a ... and Director of The Aesthetic Facial Surgery Institute of New ...
... intensive care can expect long-term quality of life at ... today in BioMed Central,s open access journal Critical ... allocation of resources to the treatment of heart attack ... other intensive care patient groups. , More than 600,000 ...
... for Healthcare Information Technology (CCHIT®) today announced that ... meets the Commission's ambulatory electronic health record (EHR) ... the CCHIT Certified seal, physicians and other providers ... product, allowing them to focus their evaluation on ...
... Universal,Health Services, Inc. (NYSE: UHS ) announced ... cash dividend of $0.08 per share on September 15,2008 ... Universal Health Services, Inc. is one of the ... and behavioral,health hospitals, and ambulatory centers nationwide and in ...
... reveal a lot about how they make decisions when feeling ... Associate Professor Uwe Dulleck, from the QUT Business Faculty, said ... it was, in fact, a natural reaction that had been ... the Australian arm of a study that was awarded an ...
... age 17 boosted odds for being heavy smoker , , THURSDAY, ... variations that affect their nicotine receptors seem to be at ... smoking before they turn 17, a new study says. ... young age are more likely to face severe nicotine dependence ...
Cached Medicine News:Health News:New Study Shows Facial Plastic Surgery Helps African American's Perserve Ethnicity 2Health News:New Study Shows Facial Plastic Surgery Helps African American's Perserve Ethnicity 3Health News:Heart attack not a death sentence 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 3Health News:Decisions under pressure: it's all in the heartbeat 2Health News:Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 2
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Research (A*STAR) and Switzerland,s Cytos Biotechnology ... dosed in a Phase 1 clinical trial with their H1N1 ... particle (VLP) technology. In this first Phase 1 clinical trial, ... its potential to protect against H1N1 influenza infection will be ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... NEW YORK, Nov. 17, 2010 ACCESS ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms ... care and diabetes, announced that two oncology posters are ... Prevention and Research Conference at the Austin Convention Center ...
... Corporation (Nasdaq: LMNX ), today announced that ... xTAG® CYP2D6 Kit, which recently received 510(k) clearance from ... test enables a personalized medicine approach to help physicians ... that are metabolized by the enzyme cytochrome P450 2D6. ...
Cached Medicine Technology:Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 2Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 3Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test 2Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test 3
... The mobile universal operating table for ... top allows for unlimited C-arm access. ... for both neurosurgical and cardiovascular procedures. ... for floor support can easily be ...
... the Cmax operating table that combines all ... table with the radiolucence and precise mobility ... most advanced, versatile surgical table on the ... support advancements in surgical procedures and imaging ...
... Table offers complete imaging access, with nearly ... and mobile imaging C-Arms can pan from ... reposition the patient. Anesthesiologists will appreciate this ... drive, quality construction, and ease of operation. ...
...
Medicine Products: